ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm.

Naveen Pemmaraju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.